Physician viewpoint: It’s too soon for insurers to lift COVID-19 waivers

Most insurers voluntarily waived co-pays, deductibles and other cost-sharing for hospitalized COVID-19 patients in 2020, but many began charging again in early 2021. Without waivers, Americans hospitalized for COVID-19 may face hospital bills totaling thousands of dollars, according to a study published May 30 in the medical preprint journal medRXiv. 

Advertisement

Using the IQVIA PharMetrics Plus for Academics Database, researchers from Ann Arbor-based Michigan Medicine analyzed 4,075 COVID-19-related hospitalizations of patients with private insurance or a Medicare Advantage plan between March and September 2020. 

They found that without waivers, a hospitalized COVID-19 patient with job-related or self-purchased insurance will face a hospital bill averaging $3,8000. Without waivers, the average bill for a hospitalized COVID-19 patient with a Medicare Advantage plan is $1,500.

“It is premature for insurers to stop protecting patients from the costs of COVID-19 hospitalizations,” Kao-Ping Chua, MD, PhD, the study’s lead author, said in a June 2 news release. “Even though hospitalization levels are decreasing, more than 20,000 people are hospitalized for COVID-19 in the U.S. right now. The pandemic is not over.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.